MRD / Regn No. : MH/23-24/02759 Date : 01/06/2026
Patient Name : MRS.USHA Age & Gender : 59 Yrs. / Female
Contact No. : 9445277342 UHID :
Ht / Wt / BMI : / 101 / BP S / BP D : 140 / 80
Allergies : NO ALLERGIES Referred By :
   
Problem List : T2DM - UNCONTROLLED (01/Jun/2026) | HTN (01/Jun/2026) |
Subjective : REC EPISODES OF PERIANAL ABSCESS
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 246 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 323 100 | HBA1C GLYCOSYLATED HEMOGLOBIN: 12.2 mg/dL | TOTAL CHOLESTEROL: 186 1 | TGL TRIGLYCERIDE: 288 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 56.0 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 73.0 mg/dL | UREA: 45 mg/dL | CREATININE: 0.7 1 | EGFR EGLOMERULAR FILTRATION RATE: 91.65 mL/min/1.73m2 | URIC ACID: 7.00 | TOTAL BILIRUBIN: 0.7 mg/dL | DIRECT BILIRUBIN: 0.2 mg/DL | INDIRECT BILURUBIN: 0.5 | AST ASPARTATE AMINOTRANSFERASE: 34 U/L | ALT ALANINE AMINOTRANSFERASE: 45 IU/L | ALBUMIN: 4.20 g/dL | SODIUM: 135 meq/L | POTASSIUM: 4.6 1 | CHLORIDE: 108 meq/L | CALCIUM: 11.3 1 | TOTAL T3: 91.71 1 | TOTAL T4: 9.14 1 | TSH THYROID STIMULATING HORMONE: 1.63 mIU/L | HB HEMOGLOBIN: 13.5 g/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET GLIMEPRIDE 2 +METFORMIN 500 + VOGLIBOSE 0.2
GLIMIWINDAR TRIO 2 		ORAL 1-0-1 AFTER FOOD
TILL NEXT VISIT
2 TABLET DAPAGLIFLOZIN 10 + SITAGLIPTIN 100
UDAPA - S 		1-0-0 AFTER FOOD
3 CAPSULE ROSUVASTATIN 5 + FENOFIBRATE 16.5MG
ROSUVAS F 		0-0-1
4 TABLET TELMISARTAN 40
TELDAR 40 		ORAL 0-0-1 AFTER FOOD
TILL NEXT VISIT
5 PIOGLITAZONE 7.5 MG
PIOZ 7.5 MG 		1-0-0 AFTER FOOD
TILL NEXT VISIT
6 TABLET METHYLCOBALAMIN+ MINERALS+VITAMINS
RENEW BT
Medicine For GENE HEALTH 		ORAL 1-0-0 AFTER FOOD
TILL NEXT VISIT
7 TABLET METOPROLOL 25MG
PROLOMET XL 25MG 		0-0-1 AFTER FOOD
8 ENSURE DIABETES POWDER ORAL
       
Refill : 0 / Substitution:    
Education :
Next Visit : 01/Jul/2026
Tests Suggested For Next Visit :
   
   

Dr. Balaji Chidambaram
MBBS, DIH, D Diab, F Diab
Tamil Nadu / 70637

This is a Computer generated Prescription

Powered By: